Cargando…
Breakthrough in treating severe coronavirus disease 2019 (COVID-19) patients in indonesia: the use of intravenous autologous activated platelet-rich plasma
Autores principales: | Karina, K., Rosliana, I., Rosadi, I., Sobariah, S., Christoffel, L.M., Novariani, R., Rosidah, S., Fatkhurohman, N., Hertati, Y., Puspitaningrum, N., Subroto, W.R., Afini, I., Ernanda, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111905/ http://dx.doi.org/10.1016/S1465324921004667 |
Ejemplares similares
-
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients
por: Karina, Karina, et al.
Publicado: (2021) -
The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study
por: Karina, Karina, et al.
Publicado: (2021) -
Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study”
por: Karina, Karina, et al.
Publicado: (2023) -
In vitro study of cartilage tissue engineering using human adipose-derived stem cells induced by platelet-rich plasma and cultured on silk fibroin scaffold
por: Rosadi, Imam, et al.
Publicado: (2019) -
Safety of Technique and Procedure of Stromal Vascular Fraction Therapy: From Liposuction to Cell Administration
por: Karina, Karina, et al.
Publicado: (2020)